Medplus Health Services (NSE:MEDPLUS) EBIT: ₹3,958 Mil (TTM As of Mar. 2026)


NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
88 GF Score
Price ₹835.00
GF Value ₹952.32
Valuation Modestly Undervalued
View Full Analysis

What is Medplus Health Services EBIT?

Medplus Health Services NSE:MEDPLUS -0.83% 88 EBIT is ₹3,958 Mil as of Mar. 2026. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 88/100 and a GF Value™ of ₹952.32 (Modestly Undervalued).

Medplus Health Services's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹1,138 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,958 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medplus Health Services's annualized ROC % for the quarter that ended in Mar. 2026 was 9.87%. Medplus Health Services's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medplus Health Services's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.66%.

Medplus Health Services  (NSE:MEDPLUS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medplus Health Services's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=3729.08 * ( 1 - 20.37% )/( (0 + 30097.98)/ 1 )
=2969.466404/30097.98
=9.87 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=39325.26 - 3097.8 - ( 6129.48 - max(0, 6892.91 - 20686.5+6129.48))
=30097.98

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Medplus Health Services's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4552.88/( ( (0 + max(0, 0)) + (15771.78 + max(9576.7, 0)) )/ 1 )
=4552.88/( ( 0 + 25348.48 )/ 1 )
=4552.88/25348.48
=17.96 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(269.59 + 13816.94 + 470.49) - (3097.8 + 0 + 1882.52)
=9576.7

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medplus Health Services's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=3958.23/108204.819
=3.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medplus Health Services EBIT Related Terms

Medplus Health Services EBIT Historical Data

* Premium members only.

The historical data trend for Medplus Health Services's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medplus Health Services EBIT Chart

Medplus Health Services Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 1,843.71 1,301.90 1,698.76 2,858.75 3,958.23

Medplus Health Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 879.57 801.31 977.54 1,041.16 1,138.22

Medplus Health Services EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Medplus Health Services's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medplus Health Services EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medplus Health Services's EV-to-EBIT falls into.


NSE:MEDPLUS
88GF Score
Medplus Health Services Ltd NSE:MEDPLUS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medplus Health Services EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,958 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹3,958 Mil mean?
Medplus Health Services (NSE:MEDPLUS) has a EBIT of ₹3,958 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medplus Health Services.
Is Medplus Health Services' EBIT too high?
Medplus Health Services' current EBIT is ₹3,958 Mil. Overall, Medplus Health Services has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' EBIT compare to competitors?
Medplus Health Services' EBIT of ₹3,958 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medplus Health Services. Medplus Health Services's current EBIT is ₹3,958 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹952.32, compared to a current price of ₹835.00 — trading 12.3% below its estimated fair value. The current EBIT is ₹3,958 Mil. Medplus Health Services' overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current EBIT is ₹3,958 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹835.00 is trading 12.3% below its estimated GF Value™ of ₹952.32. GuruFocus considers Medplus Health Services to be Modestly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • EBIT: ₹3,958 Mil
  • GF Value™: ₹952.32 vs. price of ₹835.00 (12.3% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
88GF Score

Get the complete analysis for NSE:MEDPLUS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹835.00
Price
₹952.32
GF Value